TowerBrook-owned consultant BRG is selling its Second Sight Solutions division, which helps drugmakers identify and resolve improper drug discounts, Axios Pro has learned.
Why it matters: The process comes as regulatory changes increase demand for technology that helps drugmakers manage rebates and protect revenue.
